Answers are grounded in this paper and cite their sources.
Comparative analysis reveals similar outcomes of aCD20 and aCD154 regimens in corneal xenotransplantation, highlighting effective immunosuppression strategies.
It suggests that an aCD20-based regimen produces clinical outcomes comparable to those of an aCD154-based regimen in wild-type pig-to-rhesus corneal xenotransplantation, whereas an aCD40-based regimen does not.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: